Pharmacy evidence record · researched 2026-08-20
Empower Clinic Services, LLC dba Empower Pharmacy
Empower lists compounded Semaglutide / Cyanocobalamin Injection.
Empower lists compounded Tirzepatide / Niacinamide Injection.
First-party product listing does not establish availability in every jurisdiction or under every compounding circumstance.
Regulatory compliance
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
Empower markets its patient-specific operation as a 503A pharmacy. FDA's 2025 warning letter addresses this Empower Pharmacy facility.
Section 503B
FDA documents show that Empower Clinic Services also operated an outsourcing-facility pathway under the Empower Pharma name and inspected it as such. A 2025 warning letter states that drug products failed to meet section 503B conditions. No exact Empower row was confirmed in the FDA current registry checked on 2026-08-20, so current 503B registration is not asserted.
Telehealth providers
Clinic Scout links a provider only when an explicit source names the relationship.
Regulatory history
FDA warning-letter, Form 483, compounding-action and current 503B-registry sources were checked. State-board action evidence was not completed and remains unverified.
U.S. Food and Drug Administration · 2017-05-25
FDA stated that the firm failed to receive valid prescriptions for individually identified patients for a portion of products and described insanitary conditions and CGMP violations for ineligible products.
Status not statedU.S. Food and Drug Administration · 2021-10-15
FDA stated that products failed to meet section 503B conditions, including reporting and adverse-event-procedure deficiencies; FDA also stated that some corrective actions appeared deficient.
Status not statedU.S. Food and Drug Administration · 2025-04-02
After a September 24 to October 4, 2024 inspection, FDA stated that it observed serious deficiencies in sterile-drug production and issued a Form FDA 483 on October 4, 2024.
Status not statedU.S. Food and Drug Administration · 2025-04-02
FDA stated that drugs produced at the Empower Pharma facility failed to meet conditions of section 503B necessary for outsourcing-facility exemptions; FDA issued a Form FDA 483 on August 28, 2024.
Status not statedU.S. Food and Drug Administration · 2025-11-14
FDA lists a Form FDA 483 issued to Empower Clinic Services LLC dba Empower Pharmacy in Houston on November 14, 2025.
Status not statedNo Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.
What this record verifies for you
Each line traces to a citation in the source list below — read the exact captured wording before relying on it.
No superiority claim is made for review volume, ratings, or patient sentiment.
Our state-of-the-art facilities use advanced technology and equipment to produce high-quality, custom medications at scale through our 503A pharmacy and 503B outsourcing facility.
That's why we're licensed to ship nationwide, including Puerto Rico.
Semaglutide / Cyanocobalamin Injection ... Tirzepatide / Niacinamide Injection
2009 Empower Pharmacy is Born - Shaun Noorian, our founder & CEO starts Empower Pharmacy with a vision to provide access to quality, affordable medication to patients like himself.
Failure to Meet the Conditions of Section 503A ... the investigators noted your firm did not receive valid prescriptions for individually-identified patients for a portion of the drug products you produced.
During the inspection, the FDA investigator noted that drug products produced by your facility failed to meet the conditions of section 503B.
From September 24, 2024, to October 4, 2024, U.S. Food and Drug Administration (FDA) investigators inspected your facility, Empower Clinic Services, LLC dba Empower Pharmacy, located at 7601 N Sam Houston Pkwy W Ste 100, Houston, TX 77064. FDA issued a Form FDA 483 to your firm on October 4, 2024.
Drug products you produced failed to meet the conditions of section 503B of the FDCA necessary for drugs produced by an outsourcing facility to qualify for exemptions.
Empower Clinic Services LLC dba Empower Pharmacy Houston, TX 483 issued 11/14/2025
Updated as of 8/18/2026 ... This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 10 dated first-party or regulator citation(s), 5 regulatory/action record(s), and 3 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.
Weekly price watch
One useful comparison each week. No spam, no sold lists, and you can unsubscribe anytime.